Stan Yakatan

  • Chairman and Co-founder, Katan Associates, Hermosa Beach, CA

    After 40 years as a successful CEO, entrepreneur, and operational manager, Stan Yakatan has dedicated the last 15 years of his career to sharing his experiences with management teams interested in building technology based companies. His experience as an executive is far reaching as he has served in an Executive capacity with:

    • New England Nuclear
    • EI Dupont
    • ICN Pharma
    • New Brunswick Scientific
    • Biosearch
    • Katan Associates

    These experiences have provided him with management skills and a corporate finance acumen that he enjoys sharing with others.

    He has founded or co-founded in excess of 15 companies in the United States, Canada, Israel, France and Germany and in many cases served as the initial CEO, and Chairman of these companies. He currently sits on the board of directors of several public and private companies and has advised several of the world’s leading venture capital firms including TVM (Germany), Ventana (USA), MSP (USA) and Biocapital (Canada). During the decade of the 1990’s Biocapital was the most successful health care venture capital fund in Canada.

    Stan has also served as s Senior Advisor in Life Sciences to numerous State, Provincial and Federal government agencies These roles have been largely in a effort to assist in the development of government incentives and initiatives to foster and develop regional Life Science clusters. These efforts include work in Canada from 1993 to 1999, Israel from 1999 to 2001, and Victoria, Australia from 2002 to 2008.

    Over the past few years Stan has turned his attention to the green fuels sector. Having helped the first company in the carbon credits monetization market and later facilitating the introduction of green fuel technologies to the Taiwanese and Chinese markets.

    Stan has completed and advised on numerous acquisitions and corporate finance transactions raising in excess of $1.0 billion dollars in the public and private capital financing markets. He is a frequent speaker at financial and biotechnology conferences throughout the world speaking on topics including, “Capital Raising for the Technology-Based Start-Up” and “The Need to be Global in the Quest for Capital and Partners”. Rick Biondi, Editor of Lab Business Magazine stated,” Mr. Yakatan is a venture capital raising Guru and it is part of his genetic make up.”

    Stan is currently the Chairman and CEO of Prolight Diagnostics, a company developing a revolutionary test for the point of care market Stan currently sits on the Board of Mercury Therapeutics, Inc. which is developing new drugs for diabetes and obesity and Phenomenome Discoveries, Inc., a novel biomarker company. Stan is a frequent speaker at many Life Science industry events on the topic of commercialization of early stage technology.

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!